HEMATOLOGICAL MALIGNANCIES

This is the first study testing a new drug called talquetamab in people with advanced multiple myeloma, a type of blood cancer. The main goal is to find a safe dose and understand the drug's side effects. It is for patients whose cancer has come back or stopped responding to all …

This study tested a new drug called teclistamab in people with multiple myeloma that had returned or stopped responding to standard treatments. The main goal was to find a safe and effective dose and see how well the drug worked at controlling the cancer. Researchers measured how…

This early-stage study is testing a new drug called teclistamab in adults with advanced multiple myeloma that has come back or stopped responding to standard treatments. The main goals are to find a safe and effective dose and to understand the drug's side effects. Researchers ar…

This early-stage study is testing a new drug called AZD9829 for people with certain hard-to-treat blood cancers that have a marker called CD123. The main goals are to find a safe dose and see if the drug shows early signs of fighting the cancer. It is for adults whose cancer has …

This study aimed to see if regular clinic visits and a pneumonia vaccine could help prevent infections in cancer patients after they received CAR-T cell therapy. The plan was to enroll 50 adults with blood cancers or solid tumors who were getting this specialized treatment. Resea…

This study tested whether a simple relaxation breathing exercise could help reduce nausea and vomiting in people with blood cancers who are undergoing chemotherapy. The trial involved 68 patients, with half performing the breathing exercises three times a day alongside their stan…

This study is exploring whether weighted blankets can help improve sleep for adults with blood cancers like leukemia or lymphoma. Researchers are testing if these heavier blankets, which provide gentle pressure, are practical and safe to use in an outpatient setting and if they m…